Logo - prosperia only - E normal - point  i .png
 
Addressing challenging healthcare problems in emerging markets through AI

ABOUT

PROSPERiA is a social impact spinoff from the MIT Media Lab, created to massify early detection and treatment of chronic diseases in emerging markets through solutions based on Artificial Intelligence

SOLUTIONS

Benefits

Prevent diabetes and its complications

Cost-effective detection of DR

Reduce disability caused by diabetes

Promote self-care and self-management

 

Seamless screening of diabetic blindness

Portable AI-based solution to massify early detection of diabetes & diabetic retinopathy (DR) through risk assessment calculators, non-invasive fundus camera, retinal image analysis and personalized recommendations

1

Risk of diabetes and related complications is assessed by an AI-based calculator

High risk users are screened for diabetic retinopathy using a non-invasive fondus camera

2

3

The retina images are screened for diabetic retinopathy damages by an AI algorithm

The cases with DR damage are referred to near ophthalmic centers for treatment

4

Begin your assessment today calculating your risk

Pipeline

Ophthalmic Screening 

  • Macular degeneration

  • Glaucoma

  • Cataracts

Other Chronic Conditions

  • Cardiovascular diseases risk assessment

  • Chronic kidney disease screening

 

PARTNERS

Diabetes clinics

Clinical labs

Retail pharmacies

Optical retailers

Health Insurers

Ophthalmology clinics

Public institutions

Our trusting allies include

salauno.png
devlyn_logo.png
laGenerosa.png
vitau.png
 

OUR TEAM

Highly-qualified interdisciplinary team, composed of data scientists, machine learning engineers, systems engineers and developers; with specialists in biomedical research, technology transfer, and business strategy

Alejandro Noriega

Technology Integration Director

Cristina Campero

Medical Solutions Director

Jonathan Ezban

Market Strategy Director

RECOGNITIONS
 
 
Contact us to join the fight against avoidable blindness
  • LinkedIn